306 related articles for article (PubMed ID: 20868669)
1. 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines.
Lee CS; Yang JC; Kim YJ; Jang ER; Kim W; Myung SC
Eur J Pharmacol; 2010 Dec; 649(1-3):354-61. PubMed ID: 20868669
[TBL] [Abstract][Full Text] [Related]
2. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
Lee CS; Kim YJ; Lee MS; Han ES; Lee SJ
Life Sci; 2008 Sep; 83(13-14):481-9. PubMed ID: 18721818
[TBL] [Abstract][Full Text] [Related]
3. 18β-glycyrrhetinic acid potentiates Hsp90 inhibition-induced apoptosis in human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathway.
Yang JC; Myung SC; Kim W; Lee CS
Mol Cell Biochem; 2012 Nov; 370(1-2):209-19. PubMed ID: 22865487
[TBL] [Abstract][Full Text] [Related]
4. Combined application of camptothecin and the guanylate cyclase activator YC-1: Impact on cell death and apoptosis-related proteins in ovarian carcinoma cell lines.
Lee SJ; Kim YJ; Lee CS; Bae J
Chem Biol Interact; 2009 Oct; 181(2):185-92. PubMed ID: 19481069
[TBL] [Abstract][Full Text] [Related]
5. Akt inhibitor enhances apoptotic effect of carboplatin on human epithelial ovarian carcinoma cell lines.
Lee CS; Kim YJ; Jang ER; Myung SC; Kim W
Eur J Pharmacol; 2010 Apr; 632(1-3):7-13. PubMed ID: 20096282
[TBL] [Abstract][Full Text] [Related]
6. Different effect of protein kinase B/Akt and extracellular signal-regulated kinase inhibition on trichostatin A-induced apoptosis in epithelial ovarian carcinoma cell lines.
Jang ER; Kim YJ; Myung SC; Kim W; Lee CS
Mol Cell Biochem; 2011 Jul; 353(1-2):1-11. PubMed ID: 21380726
[TBL] [Abstract][Full Text] [Related]
7. Guanylate cyclase activator YC-1 potentiates apoptotic effect of licochalcone A on human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathways.
Lee CS; Kwak SW; Kim YJ; Lee SA; Park ES; Myung SC; Kim W; Lee MS; Lee JJ
Eur J Pharmacol; 2012 May; 683(1-3):54-62. PubMed ID: 22465181
[TBL] [Abstract][Full Text] [Related]
8. Guanylate cyclase activator YC-1 enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells via activation of apoptosis-related proteins.
Lee CS; Kim YJ; Kim W; Myung SC
Basic Clin Pharmacol Toxicol; 2011 Oct; 109(4):283-91. PubMed ID: 21554547
[TBL] [Abstract][Full Text] [Related]
9. 18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells.
Lin KW; Huang AM; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Jul; 19(14):4274-85. PubMed ID: 21696969
[TBL] [Abstract][Full Text] [Related]
10. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.
Meng J; Zhang HH; Zhou CX; Li C; Zhang F; Mei QB
Oncol Rep; 2012 Jul; 28(1):384-8. PubMed ID: 22552631
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells.
Yim SB; Park SE; Lee CS
J Pharmacol Exp Ther; 2007 May; 321(2):816-22. PubMed ID: 17314199
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
Sonnemann J; Gänge J; Pilz S; Stötzer C; Ohlinger R; Belau A; Lorenz G; Beck JF
BMC Cancer; 2006 Jul; 6():183. PubMed ID: 16834771
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS
Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477
[TBL] [Abstract][Full Text] [Related]
15. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of glycyrrhizic acid and 18beta-glycyrrhetinic acid in PC12 cells via modulation of the PI3K/Akt pathway.
Kao TC; Shyu MH; Yen GC
J Agric Food Chem; 2009 Jan; 57(2):754-61. PubMed ID: 19105645
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
Choi YH
Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
[TBL] [Abstract][Full Text] [Related]
18. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
[TBL] [Abstract][Full Text] [Related]
19. Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis.
Peng B; Chang Q; Wang L; Hu Q; Wang Y; Tang J; Liu X
Gynecol Oncol; 2008 Jan; 108(1):173-81. PubMed ID: 17959232
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]